Yellow Fever: all 52 studies

Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Baseline Assessment of Skin Resident Memory T Cells in Healthy Unvaccinated ParticipantsRecruitingNCT07636551Not applicable
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
• Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 MonthsNot yet recruitingNCT06815835Phase 3
• VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)RecruitingNCT06694766Not applicable
• Yellow Fever Human Infection Model With YF-17DRecruitingNCT05901454Not applicable
• Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D VaccinationRecruitingNCT05859490Phase 1/2
• An Experimental Medicine Decipher of a Minimum Correlate of Cellular ImmunityRecruitingNCT05568953Phase 2
• Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever VaccinationNot yet recruitingNCT05450770Not applicable
• A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy InfantsRecruitingNCT05447377Phase 3
• Characterization of Human Memory Immune Responses to Prior Yellow Fever VaccinationEnrolling by invitationNCT01244802
• Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever VaccineCompletedNCT05374317Phase 4Results posted
• Trial of an Inactivated Yellow Fever Virus VaccineCompletedNCT05172544Phase 1Results posted
• Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and AsiaActive, not recruitingNCT05011123Phase 2Results posted
• Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive, not recruitingNCT04942210Phase 2Results posted
• The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever VaccinationCompletedNCT04269265Phase 1/2Results posted
• Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNCT01488890Phase 2Results posted
• A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3Results posted
• Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3Results posted
• Trial of Yellow Fever Inactivated VaccineCompletedNCT00995865Phase 1Results posted
• Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)CompletedNCT00982137Phase 2Results posted
• Phase 3 Single Arm, Open Study on vYF in AdultsCompletedNCT07222059Phase 3
• A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationActive, not recruitingNCT07103148Phase 3
• Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsCompletedNCT07002060Phase 3
• A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy AdultsCompletedNCT06998004Phase 1
• A Pilot Study to Finetune Skin Processing Procedures in Recent Vaccinees, Prior to GeKoSkimm Study Initiation (GeKoSkimm-pilot)CompletedNCT06539351Not applicable
• Immunogenicity of Yellow Fever Vaccine in a Pediatric Population Vaccinated at 12-23 Months of Age in ArgentinaActive, not recruitingNCT05644145Not applicable
• A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARILCompletedNCT05421611Phase 3
• Booster Vaccine for Yellow FeverStatus unknownNCT05332197Phase 3
• Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary StudyStatus unknownNCT04416477
• Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral InfectionCompletedNCT04267809Phase 2
• Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRCStatus unknownNCT04235361
• Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in AdultsCompletedNCT04142086Phase 1
• Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D VaccinationActive, not recruitingNCT04083430Phase 4
• Non- Inferiority Fractional-doses Trial for Yellow Fever VaccineCompletedNCT04059471Phase 4
• A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19TerminatedNCT03891420Phase 1
• Evaluation of an Infant Immunization Encouragement Program in NigeriaCompletedNCT03870061Not applicable
• Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in HumansCompletedNCT03776786Phase 1
• Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months OldCompletedNCT03725618Phase 4
• Passive Enhanced Safety Surveillance of Stamaril® Vaccine in KoreaCompletedNCT03541694
• Yellow Fever Vaccine in Patients With Rheumatic DiseasesCompletedNCT03430388Not applicable
• Clinical Study of Immunity Duration of Yellow Fever Vaccine in MilitaryCompletedNCT03338231
• Yellow Fever Vaccine on Statin/ Non Statin SubjectsCompletedNCT03116802Phase 2
• Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)CompletedNCT02991495Phase 4
• Complementary Study of the Duration of Post-vaccination Against Yellow Fever Immunity in ChildrenStatus unknownNCT02990182
• A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy VolunteersCompletedNCT02743455Phase 1
• Immunity After Two Doses of Yellow Fever VaccineCompletedNCT02572518
• Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)Active, not recruitingNCT02555072Phase 4
• The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansCompletedNCT01943305Phase 2
• The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.CompletedNCT01426243Phase 3
• Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever VaccineCompletedNCT01290055Phase 4
• Human Immune Responses to Yellow Fever VaccinationCompletedNCT00694655Phase 4
• Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy AdultsCompletedNCT00616356

← Yellow Fever overview